$2 B

DCPH Mkt cap, 07-May-2021
Deciphera Pharmaceuticals Net income (Q3, 2017)-12 M
Deciphera Pharmaceuticals EBIT (Q3, 2017)-12.2 M
Deciphera Pharmaceuticals Cash, 30-Sept-201782.1 M

Deciphera Pharmaceuticals Income Statement

Annual

USDFY, 2015FY, 2016

R&D expense

12.5m20.2m

General and administrative expense

5.1m5.7m

Operating expense total

17.6m25.8m

EBIT

(17.6m)(25.8m)

Interest expense

2.2m106.0k

Net Income

(19.8m)(25.9m)

Quarterly

USDQ3, 2016Q3, 2017

R&D expense

4.7m9.8m

General and administrative expense

1.4m2.4m

Operating expense total

6.1m12.2m

EBIT

(6.1m)(12.2m)

Interest expense

26.0k23.0k

Net Income

(6.1m)(12.0m)

Deciphera Pharmaceuticals Balance Sheet

Annual

USDFY, 2015FY, 2016

Cash

25.8m57.5m

Prepaid Expenses

606.0k791.0k

Current Assets

26.4m58.3m

PP&E

387.0k514.0k

Total Assets

26.8m58.9m

Accounts Payable

1.6m1.4m

Current Liabilities

3.1m4.6m

Total Liabilities

4.7m6.0m

Preferred Stock

137.4m192.7m

Additional Paid-in Capital

4.3m5.8m

Retained Earnings

(119.6m)(145.6m)

Total Equity

(115.3m)(139.8m)

Financial Leverage

-0.2 x-0.4 x

Quarterly

USDQ2, 2017Q3, 2017

Cash

94.0m82.1m

Prepaid Expenses

580.0k596.0k

Current Assets

94.6m82.7m

PP&E

520.0k731.0k

Total Assets

97.1m87.9m

Accounts Payable

2.9m3.1m

Current Liabilities

8.2m10.1m

Total Liabilities

9.6m11.4m

Preferred Stock

244.5m244.5m

Additional Paid-in Capital

6.8m7.8m

Retained Earnings

(163.9m)(176.0m)

Total Equity

(157.1m)(168.1m)

Financial Leverage

-0.6 x-0.5 x

Deciphera Pharmaceuticals Cash Flow

Annual

USDFY, 2015FY, 2016

Net Income

(19.8m)(25.9m)

Depreciation and Amortization

73.0k90.0k

Accounts Payable

1.2m(187.0k)

Cash From Operating Activities

(13.3m)(23.1m)

Purchases of PP&E

(142.0k)(223.0k)

Cash From Investing Activities

(142.0k)(223.0k)

Cash From Financing Activities

38.4m55.0m

Net Change in Cash

25.0m31.7m

Interest Paid

117.0106.0

Quarterly

USDQ2, 2016Q3, 2016Q2, 2017Q3, 2017

Net Income

(11.3m)(17.4m)(18.3m)(30.4m)

Depreciation and Amortization

38.0k60.0k62.0k101.0k

Accounts Payable

846.0k(349.0k)446.0k1.4m

Cash From Operating Activities

(9.8m)(16.2m)(15.1m)(23.9m)

Purchases of PP&E

(17.0k)(104.0k)(74.0k)(276.0k)

Cash From Investing Activities

(17.0k)(104.0k)(74.0k)(276.0k)

Cash From Financing Activities

(104.0k)55.1m51.7m48.9m

Net Change in Cash

(9.9m)38.9m36.5m24.7m

Interest Paid

55.081.0k49.072.0k

Deciphera Pharmaceuticals Ratios

USDFY, 2015

Financial Leverage

-0.2 x

Deciphera Pharmaceuticals Operating Metrics

Aug, 2017

Patent Applications

49

Patents (Foreign)

47

Patents (US)

11

Deciphera Pharmaceuticals Employee Rating

415 votes
Culture & Values
4
Work/Life Balance
3.5
Senior Management
3.7
Salary & Benefits
4.5
Career Opportunities
3.5
Source